People across the Western world have already started to revolt against government-enforced lockdowns that have now continued for at least the seventh week in some places. Apple’s Mobility Trends and Foursquare payments data illustrates how shelter-in-place is becoming a distant memory for some as they try to restore their lives to what it was in pre-corona times.
The latest data from Apple’s Mobility Trends shows iPhone users in the US, Germany, UK, and Italy began to ignore stay-at-home orders around mid-April. While activity is still well below average trends from January 13, the recent rebound suggests more people are violating the orders …
Apple and Foursquare data suggests many Americans are fed up with stay-at-home orders as they now venture out into a post-corona world. Such activity could be enough to spark a second coronavirus wave, and with a record amount of deaths seen on Friday, the virus crisis could be worsening.
There probably will be a second wave as vitamin D starved people come back out from their caves. And it will certainly be seized upon to preach the need for retreat. Meanwhile the looming economic collapse will kill FAR more people than the virus. As intended.
Sex offender Jeffrey Epstein had extensive ties with Harvard University, which admitted him as a Visiting Fellow and later gave him his own office, according to a review conducted by Harvard attorneys and an outside law firm. Epstein was awarded the title of Visiting Fellow, which goes to independent researchers, in 2005 despite the fact he “lacked the academic qualifications Visiting Fellows typically possess and his application proposed a course of study Epstein was unqualified to pursue,” according to the review (pdf).
Dr. Stephen Kosslyn, the chair of the Psychology Department at the time, recommended Epstein’s admission. Epstein donated $200,000 to support Kosslyn’s work between 1998 and 2002.
Epstein told the university in his application that he wanted to “study the reasons behind group behavior, such as ‘social prosthetic systems,’ and their relationship to a changing environment,” using a term invented by Kosslyn.
“That is, other people can act as ‘prosthetics’ insofar as they augment our cognitive abilities and help us to regulate our emotions—and thereby essentially serve as extensions of ourselves. I wish to understand how the brain both allows such relationships to develop and how those relationships in turn take advantage of key properties of the brain,” Epstein wrote.
Epstein paid tuition and fees to become a Visiting Fellow but “did very little to pursue his course of study,” according to the review. He was readmitted for a second year after saying in an application he wished to “find a derivation of ‘power’ (Why does everybody want it?) in an ecological social system” but withdrew following his arrest in 2006.
Epstein was accused of molesting dozens of underage girls that year. He ended up pleading guilty to one count of soliciting minors for prostitution in 2008.
Kosslyn admitted to the attorneys conducting the review that Epstein wasn’t qualified to conduct the research outlined in the application. Epstein’s educational background, lacking a college degree, was highly unusual for a Visiting Fellow.
Kosslyn in his recommendation for Epstein called the financier “extraordinarily intelligent, broadly read, and very curious.”
“Jeffrey has been a spectacular success in business, and it is clear why: He’s not just intelligent and well-informed, he’s creative, deep, extraordinarily analytic, and capable of working extremely hard,” he added.
Had His Own Office
Epstein’s involvement with Harvard didn’t stop with his criminal conviction.
The sex offender was given an office with his own telephone line in Harvard’s Program for Evolutionary Dynamics (PED), which he helped establish in 2003 with a $6.5 million donation. He also received a keycard and passcode access to the program’s offices.
Epstein is believed to have visited Harvard offices dozens of times between 2010 and 2018 after being released from jail.
“Epstein was routinely accompanied on these visits by young women, described as being in their 20s, who acted as his assistants,” the review states. According to prosecutors, many women who spent time with Epstein were underage.
Epstein would give Martin Andreas Nowak, a professor of biology and mathematics, the name of professors he wanted to meet with. Either Epstein or Nowak would invite the academics to meet with Epstein at the PED offices.
The meetings usually took place on weekends.
“Taken as a whole, the documents suggest that Epstein viewed the PED offices as available for his use whenever he wished to gather academics together to hear scholars talk about subjects Epstein found interesting,” lawyers wrote in the review.
Nowak, who lawyers said took no steps to conceal Epstein’s activities, was placed on paid administrative leave on May 1 after the review was published. Officials are probing whether Nowak violated university rules….
Exposing medical corruption on mainstream media, daily. This has been going on for many years. And the CDC has been identified as an arm of the vaccine industry… fancy that!
The Center For Disease Control has become the Marketing arm of “Global Heath’s” vaccine mania. What person is the main Vaccine Maniac? Bill Gates. RFK Jr seems to agree. Lots of info in this video.
Excellent points are made by Eugene citizens during this meeting.
The case of General Flynn, which has dragged on for years now, may finally be reaching a denouement. He was charged with and pleaded guilty to making false statements to the FBI during the Russian collusion hoax. For reasons that have not been clear, he was never sentenced. Now it appears he may never see jail and will instead see his case dropped and his guilty plea vacated. New evidence shows he was framed by members of the FBI and Department of Justice.
As is standard procedure in this age, state media has been silent on the matter, but alternative media sources are reporting on the release of classified documents hidden by the government from Flynn’s defense team in violation of the law. Thousands of documents held by his former defense team and hidden from Flynn and his new attorney’s until now have also been released in what appears to be a damage control operation by the law firm Covington & Burling.
What these new FBI documents reveal is the FBI and Department of Justice carefully planned to entrap General Flynn by tricking him into making inaccurate statements about his activities during the campaign. They did this because they wanted to remove him from his post in the White House and hoped he could be manipulated into making accusations against other administrative officials. Then they systematically lied about what Flynn said to them in his interview with the FBI.
Compounding this is the fact that the FBI and Departmental of Justice systematically withheld all documents that could be used by Flynn in his defense. One way they did this was to hide them in the special counsel operation. This prevented anyone, not just Flynn’s defense team, from discovering the plot. The sudden release of long withheld documents by Covington & Burling suggest they may have been part of the plot to entrap Flynn and get him to plead guilty to a crime.
At this stage, only a partisan fanatic thinks the principals in this whole Russian collusion caper were operating in good faith. You could make the argument that their behavior was unethical, but not necessarily illegal. Even if their actions violated the law, you could argue they did so in the belief they were within the bounds of the law. With these new revelations, it is clear they knew they were breaking the law in an effort to frame General Flynn as part of a much larger conspiracy.
One thing that is now confirmed with these new revelations is that the Special Counsel was always just part of a larger effort to cover-up this conspiracy. In fact, that was the whole point of it. The FBI and DOJ officials involved in the conspiracy would hide all of the evidence inside the counsel’s operation. This would make it impossible for the defense lawyers to access and very difficult for Congress to access. It would also prevent the administration from looking into it.
Another outrageous aspect to this case is that it appears that Flynn’s original defense team, Covington & Burling, may have been in on the plot to frame him. It’s not all that clear at this point, but the best that can be said of their actions on behalf of their client is they are the worst law firm in the country. They exist because they have resources and know how things work in Washington. Despite this, they made the sorts of errors TV writers would find too ridiculous for a legal drama….
Here’s another reason they went after Flynn:
Until recently, the concept of mandatory and mass vaccination has been only a worrisome possibility. Vaccination laws are passed and monitored at the state level, not at the federal level. But while the country was still struggling to recover from the events of September 11, 2001, and the bioterrorism scares of smallpox and anthrax threats, the groundwork to make vaccines mandatory began to change in 2003, during President George W. Bush’s State of the Union Address. On that fateful night, Bush revealed the creation of Project BioShield, a comprehensive effort to develop and make available modern, effective drugs and vaccines to protect against attack by biological and chemical weapons.
Project BioShield set forth three major components:
- Creation of a permanent indefinite funding authority to spur development of medical countermeasures enabling the government to purchase vaccines and other therapies as soon as experts believe that they can be made safe and effective
- Conferred new authority to the NIH to speed research and development of drugs and vaccines that would counter bioterrorism threats and,
- Authorized emergency “fast track provisions for the release of treatments—drugs and vaccines—still waiting for approval by the FDA ‘in the event of an emergency.”
As sweeping as those plans may seem, the legislation failed to include key provisions sought by the drug companies. Mosty importantly, complete liability protection for all of their bioterrorism products.
During 2003 and 2004, any bills that were introduced by both the House and the Senate attempting to secure complete liability protection for the industry were done through federal law. In 2005 alone, 13 bills were introduced. One such bill, The Biodefense and Pandemic Vaccine and Drug Development Act of 2005, was gaining traction.
Introduced as S. 1873 by Senators Bill Frist (R-TN) and Richard Burr (R-NC), its purpose, according to Burr’s news release, was to “create a partnership between the government and private corporations by rapidly developing effective medical drugs and vaccines to protect the United States from deliberate, accidental, and natural incidents involving biological pathogens.”
Nicknamed BioShield II, the bill planned to give unprecedented advantages to the industry and remove or severely weaken all of the safeguards that prevented dangerous vaccines, drugs, and medical devices from reaching consumers. S. 1873 was accelerated through the Senate Health, Education, Labor, and Pensions (HELP) Committee, without hearings.
Public outrage began almost immediately. Websites, news outlets, and nationwide radio hosts were exposing the unbelievable benefits the bill would convey to the drug companies. Dozens of activist groups representing many thousands of constituents rallied a campaign to notify Congress of their dissatisfaction with S.1873. Faxes, emails, and phone calls show message after message opposing the carte blanche promises drugmakers set out to receive. Because the outcry against S.1873 was so strong, the possibility of its passage was bleak.
To circumvent this outrage, Senate Majority Leader Bill Frist forced the attachment of a shortened version int HR 2863, the 2006 Department of Defense Appropriations Bill, literally at the eleventh hour. Called Division E—Public Readiness and Emergency Preparedness Act, Frist’s addendum added 40 pages to an existing 423-page bill on December 17, 2005 at 11:20 pm, well after the House Appropriation Committee members had signed off, and most had gone home. Soon referred to as the PREP Act, it gave sweeping and unprecedented immunity for drug companies for emergency products.
The PREP ACT
The PREP Act provides complete immunity from liability for any loss relating to or resulting from, any product used to prevent or treat illness during a public health emergency. The immunity applies to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of medical countermeasures described in a Declaration. The only statutory exception to this immunity is for actions or failures to act that constitute “willful misconduct.” And as we will see, even willful misconduct may not be punished. For a full explanation of the scope of the Act, go here.
Representative Dave Obey (D-WI), Ranking Member of the House Appropriations Committee made the following statement on the floor of the House on December 22, 2005:After the [Committee] finished at 6 p.m., Senator Frist (R-TN) marched over to the House side of the Capitol. He insisted 40 pages of legislation that had never been seen by Conferees be attached to the bill.Speaker Dennis Hastert (R-IL) joined Frist’s insistence and without a vote of the Conferees, the legislation was unilaterally and arrogantly inserted into the bill. [This was] a blatantly abusive power-play by two of the most powerful men in Congress.Rep. Obey’s full rebuttal – no longer available. You can read it here: Download
Sweeping Provisions Against AmericansPassed in, Senator Frist (a medical doctor) handed the drug companies (a special interest group) more immunity than any bill that has ever been passed by Congress. The legislation provides at least four sweeping provisions:
- Immunity from all liability for all drugs, vaccines or biological products deemed as a “covered countermeasure.”
- Immunity from all accountability, no matter what a drug company did wrong. Even if the company’s dirty facility created a batch of contaminated vaccines that resulted in deaths or injuries to thousands of people, the drug company will remain immune from liability.
- Immunity from all liability for any product used for any public health emergency declared by the Secretary of HHS.
- Immunity from all lawsuits. A person who suffers any type of loss will be legally prohibited from suing the drug companies; they now have immunity from almost everything, perhaps even murder.
In simple terms, if a claim is filed by a plaintiff it can only go forward if the injured party can prove that the company performed an act of willful misconduct. In other words, the injured party would have to prove the vaccine maker created a product that intentionally caused them harm.
Unbelievably, even then the drug company is still immune from accountability. Even if a pharmaceutical company knowingly harms people, the company will be immune from legal prosecution unless the U.S. Attorney General initiates enforcement action against the drug company in the name of the claimant. This means the U.S. government would have to go to bat for the plaintiff against the drug company for the lawsuit to move forward.
Fast Forward: COVID19
Wasting no time, the Secretary of HHS, Alex Azar and the Assistant Secretary for Preparedness and Response Robert P. Kadlec, MD, MTM&H, MS, issued Notice of Declaration of National Emergency and published in the Federal Register on March 17, 2020 (Vol. 85, No. 52). The Declaration was effective as of February 4, 2020. By declaring a national emergency for the SARS-CoV-19 virus and COVID-19, the Secretary evoked the PREP Act “to provide liability immunity for activities related to medical countermeasures against COVID–19.”
Once this new, experimental COVID-19 vaccine is deemed to be a “covered countermeasure” there will be no going back. How can an experimental vaccine exist to protect from a virus that little is known about? Can you think of a worse-case outcome for many? The mainstream media is conditioning people to anticipate and even beg for this vaccine. It’s all part of the Plan.
The Time for Mass Vaccination in Adults Has Arrived
The National Vaccine Plan (NVP) for adults was released in February 2010. It lays out the strategy to vaccinate all adults with all approved vaccines and “any vaccine that is approved, now and in the future.” …
I’ve been sitting back, listening to and watching the crushing plan “they” have designed for us. I’ve been viewing this fiasco through the lens of history. I wrote this article to give you some perspective. I couldn’t help but think when this COVID19 blitz started, “How soon we forget.”
Over the last three weeks, unless you have been cloistered in a monastery in Tibet, you have been bombarded with at least 2.1 billion media mentions regarding a new form of coronavirus that has spread rapidly around the world. As a comparison, when Ebola was in the news last year, it received a mere 16.3 million media mentions.
The world economy has ground to a stop over the pandemic spread of coronavirus SARS-CoV2, the proper name for the virus. This name was chosen because the virus is genetically related to the coronavirus responsible for the SARS outbreak of 2003. The SARS-CoV2 virus is the cause of the coronavirus disease 2019, or COVID-19. The two terms are in use interchangeably but the words are not synonyms.
According to the CDC, coronaviruses are named for the crown-like spikes on their surface. There are 36 coronaviruses in the family Coronaviridae. The viruses cause respiratory or intestinal infections in humans and some animals. These common, mostly benign respiratory viruses were first identified in humans in the mid-1960s.
The coronaviruses that commonly infect people are:
- 229E (alpha coronavirus)
- NL63 (alpha coronavirus)
- OC43 (beta coronavirus)
- HKU1 (beta coronavirus)
These four common human viruses cause 10–20% of respiratory infections worldwide and are present on all continents. Most likely, you’ve had exposure to, and perhaps ill from, a coronavirus infection at some point in your life. And you may actually have some level of natural immunity to this virus.
Round #1, 2002: SARS—Coronavirus
The first reported case of the “mysterious flu” was reported in November 2002. Scientists went into high gear and found this highly pathogenic coronavirus originating in the Guangdong province in China. Experts were concerned because there were no previous cases in humans before. Named SARS-CoV, for “severe acute respiratory syndrome caused by a coronavirus,” its spread set off panicked alerts across the globe. The WHO issued its first global alerts in early March 2003. The alerts went out even though the majority of cases were mostly in the Chinese province.
Ten years later a similar, highly pathogenic coronavirus called the Middle East respiratory syndrome coronavirus (MERS-CoV) would emerge in Middle Eastern countries leading to severe respiratory distress syndrome in humans.
Teams of experts went to investigate the SARS outbreak. The hysteria ramped up quickly, and within weeks, the Hong Kong Department of Health issued an unprecedented quarantine order. And order to keep residents inside their homes. Shortly thereafter, Mainland China followed suit, closing public schools, cinemas, and libraries. The closures being an attempt to stop the spread of the virus. As reports of more cases came into Toronto, Canadian health officials warned residents to quarantine themselves, wear masks, and in some cases, just stay home.
Over the six month duration of the pandemic, 8,049 people tested positive for the virus. The vast majority of cases occurred in China, Hong Kong, and Taiwan, with a resulting 774 deaths, or close to 10% of known cases.
But since the total number of cases only represents those ill enough to seek medical help, the actual death rate is unknown and may have been far less.
Economic Implications With Minimal Affected
In spite of the fact that few people in Canada were affected (251) and even fewer died (43), the Canadian Tourism Board estimated that the SARS epidemic cost the nation’s economy $419 million. The Ontario health minister reported that the cost to the province’s health-care system, including money spent to develop special clinics and stock them with supplies to protect healthcare workers, was nearly $763 million.
SARS had a significant effect on the airline industry. Singapore Airlines lost $6 million each day during April and May when SARS choked off intra- and inter-Asian travel. Other less obvious industries that suffered during the outbreak were retail sales, hotels, and restaurants. When translated into an absolute dollar amount, these figures imply that the global economic loss from SARS was close to $40 billion U.S. in 2003. This figure is much greater than the medical costs of treating SARS patients.
Is this sounding familiar?
As SARS-CoV faded into obscurity in 2004, and has never been seen again, a new pandemic was coming to the forefront. But this time, it was an influenza virus, H5N1, that was gaining the attention of the WHO and the mainstream media.
Identifying influenza viruses is based on three distinct immunogenic types—A, B, and C—and a large number of subtypes. Type C viruses are either assymptomatic or very mild respiratory illness and do not carry with them a public health impact. Influenza type B infections also tend to cause minor illnesses. Having a propensity for older persons, influenza type B viruses are most oftenly occur in nursing home outbreaks. Research shows influenza types C and B as only active in humans. Until the emergence of the H5N1 virus, the only influenza A viruses in humans, since 1977, have been H1N1, H1N2, and H3N2.
Influenza A subtypes have been designated as either mildly pathogenic, meaning they cause minimal or no disease. Or they can be highly pathogenic, meaning their presence has been associated with widespread infection. The antigen subtypes H5, H7, and H9 are the cause of all outbreaks of highly pathogenic influenza. This has been the case since the 1980s.
Round #2, 2005: Bird Flu, H5N1
A pandemic by definition is an outbreak of an infection occurring over a very wide area, crossing international boundaries and usually affects a large number of people. By those standards, the bird flu exploded onto the world stage in May 1997 through an ironically innocent setting.
It Started in a Zoo
A Hong Kong pre-school had set up a small petting zoo on its grounds, making a home for five chickens and eight ducks. The children were happy to spend time with their feathered friends. Several days after the school aviary experience, a three-year-old boy began to cough. The illness and fever progressed rapidly, and the boy’s parents rushed him to Victoria Hospital where he was admitted with pneumonia and respiratory distress. Six days later, he died.
Pathologists found no underlying immunodeficiency or cardiopulmonary disease that would have contributed to the boy’s death. Three months later, the virus was confirmed to be avian influenza A virus with surface antigens H5N1. In a report published later, researchers held that this particular bird flu virus had not previously caused infection in humans.
Teams from the WHO and the CDC descended on Hong Kong to determine how the boy had been exposed to the bird flu virus and to assess the potential public health impact. According to investigators, one of the chickens in the petting zoo had died several days before the child’s symptoms had appeared. Postulation suggests that there was exposure to the ill bird, meaning, the virus had “jumped species” to infect the boy.
In the following days and weeks, officials began scrambling to determine if the virus infection had spread to those who had come in contact with the ill child. Approximately 2,000 human samples were collected from those who had been in contact with the boy, the school’s petting zoo, or the birds from the rural areas. No additional cases were identified. Then, a second case of H5N1 infection was confirmed in Hong Kong. Then, 18 more cases appeared over the following months. With news of the direct bird-to-human transmission, the CDC and WHO believed the next pandemic had arrived.
Again, is this sounding familiar?
Throughout the evolving epidemic, China denied the presence of bird flu in chickens or humans. However, that changed in 2005 when China reported 7 human cases with three deaths to the WHO. All across the expansive country, millions of farmers were living in close proximity to billions of chickens, the reservoir of the H5N1 virus. Reporting only seven H5N1 human infections seems extraordinarily low. Many virologists around the world have questioned the relative absence of human cases, given there were 30 highly pathogenic viral outbreaks in poultry across ten provinces throughout 2005.
China lied twice before; is there any doubt they could very well be lying now?
Round #3, 2009: Swine Flu (H1N1)
In the spring of 2009, another pandemic siren shrieked across the US and around the world. This time, it was over a novel strain of influenza A. With the origin and discovery of the virus in pigs from a small region in central Mexico, the outbreak became known as “swine flu” and the viral nomenclature was H1N1. The WHO quickly declared a “public health emergency of international concern.” By June, the WHO and the CDC stopped counting cases. The next step was to declare the swine flu outbreak as a pandemic.
About that same time, experts around the world were saying that this H1N1 swine flu virus was not aggressive enough to cause a worldwide pandemic. They noted that the mortality rate among confirmed cases was 1.6% in Mexico and only 0.1% in the United States. At press conferences, various medical experts made remarks such as, “It is unclear if we need to use vaccines against the swine flu because the virus does not have a pandemic nature.” Additional remarks include, “Does the world really needs a vaccine for an illness that so far appears mild?”
Onto the Fast-Track
Nonetheless, loaded with government funds, the Big Boys in vaccine manufacturing plowed ahead. By September, Pandemrix and Arepanrix, both made by GlaxoSmithKline (GSK) were approved. Focetria, made by Novartis was also approved for use the following month. Celvapan, a whole virus vaccine made by Baxter was approved but soon withdrawn from market because it caused extremely high fevers. …